A systematic review of mechanisms of change in mindfulness-based cognitive therapy in the treatment of recurrent major depressive disorder

Clinical Psychology Review
Anne Maj van der VeldenJacob Piet

Abstract

The investigation of treatment mechanisms in randomized controlled trials has considerable clinical and theoretical relevance. Despite the empirical support for the effect of mindfulness-based cognitive therapy (MBCT) in the treatment of recurrent major depressive disorder (MDD), the specific mechanisms by which MBCT leads to therapeutic change remain unclear. By means of a systematic review we evaluate how the field is progressing in its empirical investigation of mechanisms of change in MBCT for recurrent MDD. To identify relevant studies, a systematic search was conducted. Studies were coded and ranked for quality. The search produced 476 articles, of which 23 were included. In line with the theoretical premise, 12 studies found that alterations in mindfulness, rumination, worry, compassion, or meta-awareness were associated with, predicted or mediated MBCT's effect on treatment outcome. In addition, preliminary studies indicated that alterations in attention, memory specificity, self-discrepancy, emotional reactivity and momentary positive and negative affect might play a role in how MBCT exerts its clinical effects. The results suggest that MBCT could work through some of the MBCT model's theoretically predicted mechanisms...Continue Reading

References

Jan 1, 1978·Biophysical Journal·M B Weissman
Jan 1, 1990·Behaviour Research and Therapy·T J MeyerT D Borkovec
Sep 1, 1987·The Journal of Nervous and Mental Disease·M Csikszentmihalyi, R Larson
Feb 1, 1996·Controlled Clinical Trials·A R JadadH J McQuay
Mar 21, 1998·Psychopathology·E S Paykel
Dec 16, 2000·Journal of Personality Assessment·M ConwayC K Blake
May 19, 2001·Journal of Abnormal Psychology·E Watkins, J D Teasdale
Oct 9, 2002·Archives of General Psychiatry·Helena Chmura KraemerW Stewart Agras
Apr 22, 2003·Journal of Personality and Social Psychology·Kirk Warren Brown, Richard M Ryan
Feb 6, 2004·Journal of Consulting and Clinical Psychology·S Helen Ma, John D Teasdale
Dec 31, 2005·Journal of Clinical Psychology·Shauna L ShapiroBenedict Freedman
Jul 5, 2006·Archives of General Psychiatry·Zindel V SegalTom Buis
Oct 5, 2006·Journal of Clinical Psychology·Mark A LauGerald Devins
Apr 12, 2007·Neuroreport·Thorsten BarnhoferJ Mark G Williams
Aug 25, 2007·Annual Review of Clinical Psychology·Alan E Kazdin
Dec 19, 2007·Journal of Consulting and Clinical Psychology·Helen F CoelhoEdzard Ernst
Jul 17, 2008·The American Journal of Psychiatry·Aaron T Beck
Nov 1, 2008·The Journal of Nervous and Mental Disease·Johannes MichalakDietmar Schulte
Nov 18, 2008·Behaviour Research and Therapy·Rebecca MurphyChristopher G Fairburn
Nov 27, 2008·Psychotherapy Research : Journal of the Society for Psychotherapy Research·Alan E Kazdin
Apr 22, 2009·Epidemiologia e psichiatria sociale·Ronald C KesslerPhilip S Wang
Jul 22, 2009·PLoS Medicine·David MoherUNKNOWN PRISMA Group
Jul 23, 2009·BMJ : British Medical Journal·David MoherUNKNOWN PRISMA Group
Mar 31, 2010·Journal of Consulting and Clinical Psychology·Stefan G HofmannDiana Oh
May 25, 2010·Behaviour Research and Therapy·Winston A Sanders, Dominic H Lam
Sep 3, 2010·Behaviour Research and Therapy·Willem KuykenTim Dalgleish
Nov 13, 2010·Psychiatry Research·Britta K HölzelSara W Lazar
Nov 26, 2010·Journal of Affective Disorders·Vijaya ManicavasgarTania Perich
Nov 16, 2011·The American Psychologist·Alan E Kazdin

❮ Previous
Next ❯

Citations

Mar 26, 2016·Translational Behavioral Medicine·Yi-Yuan Tang, Leslie D Leve
Jun 18, 2015·Nature Reviews. Neuroscience·Anne Maj van der Velden, Andreas Roepstorff
May 6, 2016·Frontiers in Psychology·Simone BiancoArianna Palmieri
Nov 11, 2016·European Archives of Psychiatry and Clinical Neuroscience·Jonathan GreenbergSara W Lazar
Dec 30, 2016·Psychological Medicine·R S CraneW Kuyken
Feb 20, 2017·Consciousness and Cognition·Ausiàs CebollaRosa María Baños
Aug 4, 2016·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Sagar V ParikhUNKNOWN CANMAT Depression Work Group
Nov 10, 2017·Journal of Personality Disorders·Hannah J ScheibnerFelix Bermpohl
Nov 23, 2017·European Journal of Psychotraumatology·Lonneke I M LenferinkPaul A Boelen
Dec 12, 2018·Annual Review of Clinical Psychology·Joseph WielgoszRichard J Davidson
Apr 26, 2019·Expert Review of Neurotherapeutics·Matthew J KnightBernhard T Baune
May 30, 2019·Behavioral Medicine·Nicole R NugentLisa A Uebelacker
Nov 7, 2019·Psychotherapy Research : Journal of the Society for Psychotherapy Research·Christine HofheinzJohannes Michalak
Jun 17, 2020·International Journal of Qualitative Studies on Health and Well-being·Elisabeth SchancheGeir Høstmark Nielsen
Apr 2, 2020·The Journal of Nervous and Mental Disease·Jonathan Bronchain, Henri Chabrol
Sep 13, 2018·International Journal of Adolescent Medicine and Health·Somboon JarukasemthaweeNatalia Lara González
Mar 23, 2017·Frontiers in Psychology·Simón GuendelmanHagen Rampes
Oct 7, 2017·Early Intervention in Psychiatry·Catherine Johnson, Tracey Wade
May 11, 2018·Neuropsychological Rehabilitation·Elizabeth Jane BeadleDavid H K Shum
Dec 12, 2019·Psychotherapy Research : Journal of the Society for Psychotherapy Research·Carly YasinskiWillem Kuyken
Jul 1, 2020·Pilot and Feasibility Studies·Fiona J R EcclesJane Simpson
Jun 6, 2020·Frontiers in Psychiatry·Zina-Mary Manjaly, Sandra Iglesias
Nov 18, 2015·Current Opinion in Psychiatry·Zindel V Segal, Kathleen M Walsh
Oct 23, 2019·Experimental Biology and Medicine·Megan E BeerseGregg D Stanwood

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here